Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Unresectable Hepatocellular Carcinoma: Efficacy and Systemic Immune Response.
Yang F, Xu GL, Huang JT, Yin Y, Xiang W, Zhong BY, Li WC, Shen J, Zhang S, Yang J, Sun HP, Wang WS, Zhu XL. Yang F, et al. Among authors: huang jt. Front Immunol. 2022 Feb 18;13:847601. doi: 10.3389/fimmu.2022.847601. eCollection 2022. Front Immunol. 2022. PMID: 35300339 Free PMC article.
Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma.
Huang JT, Zhong BY, Jiang N, Li WC, Zhang S, Yin Y, Yang J, Shen J, Wang WS, Zhu XL. Huang JT, et al. J Hepatocell Carcinoma. 2022 Nov 30;9:1217-1228. doi: 10.2147/JHC.S386672. eCollection 2022. J Hepatocell Carcinoma. 2022. PMID: 36474670 Free PMC article.
467 results